werfen-logo

GEM7000-Logo_REV

SHINING NEW LIGHT 
ON A HIDDEN PROBLEM

Hemolysis accounts for up to 70% of preanalytical errors.1

The NEW GEM Premier 7000 with iQM3* is the first and only blood gas system to provide lab-quality hemolysis detection right at the point of care. Hemolysis elevates potassium by up to 152%—tackle the #1 preanalytical error and elevate patient care.2–4

GEM7000-Analyzer-web-singleflag
Baby1

Express Hemolysis Detection 

Blood gas results with hemolysis detection in 45 seconds at the point of care, which may reduce the need to send samples to the lab for recheck, saving blood and time.5

Analyzer

Innovation Meets Accuracy 

Our patented blood-separation and detection technology accurately determines the level of hemolysis in whole blood, eliminating the need for centrifugation. It provides lab-quality results in any acute care setting.

nurse1

Track-to-Train

Go beyond detection. Lower preanalytical error rates due to hemolysis with GEMweb® Plus 500 Custom Connectivity by tracking operators and locations to identify where further training is required. Plus, Werfen Academy can provide the necessary content for instruction. 

Analyzer2

Effective And Efficient

Whole blood hemolysis detection can help reduce unnecessary sample collection, delays, and inappropriate treatment. Ultimately, it can assist with optimizing staff time, reduce costs, and improve patient management.4,6–9

It’s crucial to have the latest technology at the point of care. The GEM Premier 7000 provides precise measurements for blood gases, pH, electrolytes, and metabolites. What truly sets it apart is our iQM3 technology. It revolutionizes the point-of-care experience by simultaneously detecting and flagging hemolysis in potassium results, in real time. On top of that, it continuously monitors samples to detect and document micro-clots, bubbles and other errors, ensuring quality before, during, and after each analysis.

Act Now to Reduce Inappropriate Patient Management 2,4,5–7

The GEM Premier 7000 with iQM3 delivers the insight, continuous quality management, and improved efficiency your lab needs to stay ahead.

 

 

Request More Information
  1. Lippi G, Salvagno GL, Favaloro EJ, Guidi GC. Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement. Clin Chem Lab Med. 2009;47(5):616–618. doi:10.1515/CCLM.2009.132.
  2. Lippi G, Fontana R, Avanzini P, Sandei F, Ippolito L. Influence of spurious hemolysis on blood gas analysis. Clin Chem Lab Med. 2013;51(8):1651–1654. doi:10.1515/cclm-2012-0802.
  3. Lippi G, von Meyer A, Cadamuro J, Simundic A-M. Blood sample quality. Diagnosis. 2018;6(1):25–31. doi:10.1515/dx-2018-0018.
  4. O’Hara M, Wheatley EG, Kazmierczak SC. The impact of undetected in vitro hemolysis or sample contamination on patient care and outcomes in point-of-care testing: a retrospective study. J Appl Lab Med. 2020;5(2):332–341. doi:10.1093/jalm/jfz020.
  5. Werfen. GEM Premier 7000 with iQM3 Operators Manual. P/N 00000026407. Rev 00. Aug 2023.
  6. Phelan MP, Hustey FM, Good DM, Reineks EZ. Seeing red: blood sample hemolysis is associated with prolonged emergency department throughput. J Appl Lab Med. 2020;5(4):732–737. doi:10.1093/jalm/jfaa073.
  7. Wilson M, Adelman S, Maitre JB, et al. Accuracy of hemolyzed potassium levels in the emergency department. West J Emerg Med. 2020;21(6):272–275. doi:10.5811/westjem.2020.8.46812.
  8. Milutinović D, Andrijević I, Ličina M, Andrijević L. Confidence level in venipuncture and knowledge on causes of in vitro hemolysis among healthcare professionals. Biochem Med. 2015;25(3):401–409. doi:10.11613/BM.2015.040.
  9. Phelan MP, Ramos C, Walker LE, et al. The hidden cost of hemolyzed blood samples in the emergency department. J Appl Lab Med. 2021;6(6):1607–1610. doi:10.1093/jalm/jfab035.

       *Not available in all countries.

G7K Shine LP WW REV00 12.24

Baby1

Express Hemolysis Detection 

Blood gas results with hemolysis detection in 45 seconds at the point of care, which may reduce the need to send samples to the lab for recheck, saving blood and time.5

Analyzer

Innovation Meets Accuracy 

Our patented blood-separation and detection technology accurately determines the level of hemolysis in whole blood, eliminating the need for centrifugation. It provides lab-quality results in any acute care setting.

nurse1

Track-to-Train

Go beyond detection. Lower preanalytical error rates due to hemolysis with GEMweb® Plus 500 Custom Connectivity by tracking operators and locations to identify where further training is required. Plus, Werfen Academy can provide the necessary content for instruction. 

nurse2

Effective And Efficient

Whole blood hemolysis detection can help reduce unnecessary sample collection, delays, and inappropriate treatment. Ultimately, it can assist with optimizing staff time, reduce costs, and improve patient management.4,6–9